• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17988 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Center for Evidence-based Practice (CEP) Timing of valve replacement for patients with infective endocarditis and intracranial embolism
2019     NIHR Public Health Research (PHR) programme How can interventions integrating health and academic education in schools help prevent substance misuse and violence, and reduce health inequalities among young people? Systematic review and evidence synthesis
2019     Center for Evidence-based Practice (CEP) Participation in athletics by persons with thoracic aortic disease
2019     NIHR Health Services and Delivery Research programme Evaluating the ten year impact of the Productive Ward at the clinical microsystem level in English acute trusts
2019     Health Quality Ontario (HQO) Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019     Center for Evidence-based Practice (CEP) Postoperative chlorhexidine bathing to reduce surgical site infections among patients undergoing cardiac surgery
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: dose banding and dose rounding of antineoplastic agents]
2019     Adelaide Health Technology Assessment (AHTA) Heritable Mutations associated with Familial Hypercholesterolaemia
2019     NIHR Public Health Research (PHR) programme Mass media for public health messages
2019     European Network for Health Technology Assessment (EUnetHTA) Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy
2019     European Network for Health Technology Assessment (EUnetHTA) Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response with, lost response to or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies
2019     NIHR Health Services and Delivery Research programme Investigating the contribution of physician associates (PAs) to secondary care in England: a mixed methods study
2019     Health Quality Ontario (HQO) Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019     Health Technology Wales (HTW) Procalcitonin point-of-care testing for initial assessment of suspected sepsis
2019     NIHR Health Technology Assessment programme Platelet Rich Plasma (PRP) in Achilles Tendon Rupture (ATR) healing
2019     Technology Assessment at SickKids (TASK) The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019     Health Technology Wales (HTW) Fluorine- or gallium- prostate-specific membrane antigen (PSMA) positron emission tomography (PET) radiotracers in the investigation of recurrent prostate cancer
2019     NIHR Health Technology Assessment programme Models Of Reablement Evaluation: a mixed methods evaluation of a complex intervention (The MORE project)
2019     Technology Assessment at SickKids (TASK) A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2019     Health Technology Wales (HTW) Synovasure® Alpha Defensin Lateral Flow Test Kit for the assessment of periprosthetic joint infection
2019     Health Quality Ontario (HQO) Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment
2019     Health Technology Wales (HTW) Hand-held ultrasound devices for cardiac assessment and diagnosis of heart failure, in the community or primary care setting
2019     Health Technology Wales (HTW) Continuous glucose monitoring systems for managing diabetes in pregnant women
2019     Health Quality Ontario (HQO) Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis
2019     Health Technology Wales (HTW) Pharmacogenetic testing to identify the risk of adverse reactions to anti-epileptic medications
2019     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2019     Health Technology Wales (HTW) Robot-assisted thoracic surgery
2019     NIHR Health Services and Delivery Research programme Innovation to enhance health in care homes: rapid evidence synthesis
2019     Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019     Health Technology Wales (HTW) Occipital nerve stimulation for medically refractory chronic cluster headache
2019     Health Sciences Institute in Aragon (IACS) Efficacy, effectiveness and safety of intraoperative radiotherapy in breast carcinoma
2019     NIHR Health Technology Assessment programme The Effectiveness and cost-effectiveness of Surgical Treatments for womEn with stRess urinary incontinence: an evidence synthesis (ESTER)
2019     Health Sciences Institute in Aragon (IACS) Detection of diabetes' complications. Diabetic retinopathy. Economic evaluation of ultra-wide field scanning laser
2019     Health Technology Wales (HTW) Multi-grip myoelectric upper-limb prosthetics
2019     European Network for Health Technology Assessment (EUnetHTA) Stool DNA testing for early detection of colorectal cancer
2019     Ontario Health Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment
2019     European Network for Health Technology Assessment (EUnetHTA) C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs)
2019     European Network for Health Technology Assessment (EUnetHTA) Robot-assisted surgery in thoracic and visceral indications
2019     NIHR Public Health Research (PHR) programme NAP SACC UK: a feasibility cluster randomised controlled trial in child care settings to increase physical activity and healthy eating in 2-4 year olds
2019     European Network for Health Technology Assessment (EUnetHTA) Irreversible electroporation for the treatment of liver and pancreatic cancer
2019     Ontario Health Minimally Invasive Glaucoma Surgery: A Budget Impact Analysis and Evaluation of Patients’ Experiences, Preferences, and Values
2019     European Network for Health Technology Assessment (EUnetHTA) Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease)
2019     NIHR Health Technology Assessment programme Behavioural Activation Therapy for Depression after Stroke (BEADS): a feasibility randomised controlled pilot trial of a psychological intervention for post-stroke depression
2019     European Network for Health Technology Assessment (EUnetHTA) Lithium triborate (LBO) laser for photoselective vaporisation of the prostate (PVP) in the treatment of benign prostatic hyperplasia (BPH)
2019     NIHR Public Health Research (PHR) programme Adapting a falls prevention exercise programme with and for older people with visual impairment: a feasibility study
2019     European Network for Health Technology Assessment (EUnetHTA) Regional hyperthermia for high-risk soft tissue sarcoma treatment
2019     Belgian Health Care Knowledge Centre (KCE) Polyvalent immunoglobulins – Part 1: A rapid review
2019     European Network for Health Technology Assessment (EUnetHTA) Screening for osteoporosis in the general population
2019     European Network for Health Technology Assessment (EUnetHTA) Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)
2019     European Network for Health Technology Assessment (EUnetHTA) Point-of-care tests (POCT): D-dimer and troponin
2019     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Enzalutamide (prostate cancer) - Addendum to Commission A18-80]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Indications, utility and use of ultrasound in primary care]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants]
2019     Belgian Health Care Knowledge Centre (KCE) Bariatric surgery : an HTA report on the efficacy, safety and cost-effectiveness
2019     Basque Office for Health Technology Assessment (OSTEBA) [Methodological project: Synthesis of information in support of multicriteria decision analysis (MCDA) for decision making]
2019     Belgian Health Care Knowledge Centre (KCE) Cost-effectiveness analysis of HPV vaccination of boys in Belgium
2019     Belgian Health Care Knowledge Centre (KCE) The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: smoking cessation strategies]
2019     Belgian Health Care Knowledge Centre (KCE) Proton beam therapy in adults
2019     Belgian Health Care Knowledge Centre (KCE) Statins for the primary prevention of cardiovascular events
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: considerations relating to the adoption of the learning health-care system approach, the reflective approach, and audit and feedback in the context of managing chronic diseases and multimorbid states]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: respiratory multiplex NAAT (8 or more targets)]
2019     NIHR Health Services and Delivery Research programme Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019     NIHR Health Services and Delivery Research programme Innovation to enhance health in care homes and evaluation of tools for measuring outcomes of care: rapid evidence synthesis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: use of rifapentine in the treatment of latent tuberculosis infection]
2019     NIHR Health Services and Delivery Research programme Digital and online symptom checkers and assessment services for urgent care to inform a new digital platform: a systematic review
2019     NIHR Health Services and Delivery Research programme Improving care for women and girls who have undergone female genital mutilation/cutting: qualitative systematic reviews
2019     NIHR Health Services and Delivery Research programme Multicomponent hospital-led interventions to reduce hospital stay for older adults following elective surgery: a systematic review
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of linear accelerators with on-board magnetic resonance imaging (MRI) for real-time MRI-guided radiation therapy treatments]
2018     NIHR Health Technology Assessment programme Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Immunoglobulin for myasthenia gravis chronic treatment]
2018     NIHR Health Technology Assessment programme Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation
2018     Center for Evidence-based Practice (CEP) Update: Best practices for central venous catheter removal
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [PET/CT scan for solitary pulmonary nodule and non-small cell lung cancer]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sofosbuvir (hepatitis C in adolescents) - benefit assessment according to §35a Social Code Book V]
2018     NIHR Health Technology Assessment programme Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review
2018     Center for Evidence-based Practice (CEP) Point-of Care Ultrasound for Acute Respiratory Distress
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [LDL-Apheresis in familial hypercholesterolemia and hypertriglyceridemia]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (renal cell carcinoma) - benefit assessment according to §35a Social Code Book V]
2018     NIHR Health Technology Assessment programme Brain and spinal stimulation therapies for phantom limb pain: a systematic review
2018     Center for Evidence-based Practice (CEP) Monitoring of Anticoagulation in Patients on Extracorporeal Membrane Oxygenation
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge on organizational models for intensive care units]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Abemaciclib, palbociclib and ribociclib in breast cancer]
2018     NIHR Health Technology Assessment programme Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews
2018     Center for Evidence-based Practice (CEP) Transjugular Intrahepatic Portosystemic Shunts for Patients with Acute Variceal Bleeding
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards, English version updated in June 2020: requirements relating to the institutions responsible for the operation of acute healthcare facilities designated within the Quebec trauma network]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [T2 mapping for articular cartilage assessment]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Obinutuzumab (non-pretreated advanced follicular lymphoma) - assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
2018     Center for Evidence-based Practice (CEP) Update: Anticoagulation Management in Paracentesis and Thoracentesis
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Pyridostigmine with aminopyridines in myasthenia gravis or Lambert-Eaton myasthenic syndrome]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Midostaurin (acute myeloid leukaemia) - assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018     Center for Evidence-based Practice (CEP) Home Administration of Intravenous Immunoglobulin
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: best practices for runaway prevention and intervention for youths living in rehabilitation centres for young persons with adjustment problems]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Natalizumab for recurrent-remitting and JC virus seropositive multiple sclerosis]
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Telotristat ethyl (carcinoid syndrome diarrhoea) - benefit assessment according to §35a (1), sentence 11, Social Code Book V]